Stocktoria

Coya Therapeutics, Inc. COYA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-12-29

Coya Therapeutics, Inc. statistics & valuation

Market cap$129.0M
P / S16.2×
P / B3.0×
Net margin-267.1%
Return on equity-49.3%
Return on capital-51.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-133.10% -418.70% -267.10% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
-131.70% -485.40% -283.90% 20212022202320242025
Return on equity (%)
-134.30% -22.40% -37.60% -49.30% 20212022202320242025
Shares outstanding
2.6M 2.6M 14.4M 16.7M 20.9M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-102.10% -145.80% -19.40% -33.60% -42.50% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$1.89 -$4.73 -$0.79 -$0.98 -$1.27 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin-283.9%-485.4%-131.7%——
Net margin-267.1%-418.7%-133.1%——
Return on assets-42.5%-33.6%-19.4%-145.8%-102.1%
Return on equity-49.3%-37.6%-22.4%145.9%-134.3%
Current ratio8.5011.598.151.883.99

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.